These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 4099412)

  • 1. Thrombo-embolic phenomena in prosttic cancer.
    Farnsworth RH; Ham JM; Murnaghan GF
    Br J Urol; 1970 Dec; 42(6):743. PubMed ID: 4099412
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet adhesiveness and lipoprotein lipase activity in patients with benign and malignant disease of the prostate.
    Ham JM; Jones M; Kemp D
    Br J Surg; 1972 Jan; 59(1):60-2. PubMed ID: 5007673
    [No Abstract]   [Full Text] [Related]  

  • 3. [Recurrent thrombosis of the subclavian vein during estrogen therapy of prostatic cancer].
    Carl P
    Dtsch Med Wochenschr; 1985 Jan; 110(4):155. PubMed ID: 3967599
    [No Abstract]   [Full Text] [Related]  

  • 4. [Expression of COX-2 in prostatic cancer and benign prostatic hyperplasia].
    Zang T; Sun F; Li Y
    Zhonghua Wai Ke Za Zhi; 2001 Sep; 39(9):702-3. PubMed ID: 11769607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Reflexions on the palliative surgical treatment of prostatic cancer].
    Schimmel F
    J Urol Nephrol (Paris); 1971; 77(10):839-48. PubMed ID: 4108255
    [No Abstract]   [Full Text] [Related]  

  • 6. [X-ray prevention of gynecomastia in prostatic carcinoma patients during estrogen therapy].
    Alfthan OS; Holsti LR
    Duodecim; 1967; 83(22):1280-4. PubMed ID: 5594518
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cancer of the prostate. Morbidity and mortality with estrogen therapy].
    Ous S; Fryjordet A; Waaler G
    Tidsskr Nor Laegeforen; 1974 Apr; 94(12):748-51. PubMed ID: 4830337
    [No Abstract]   [Full Text] [Related]  

  • 8. Fibrinogenopenia, bleeding and intravascular coagulation in cancer of the prostate. Report of a case.
    Andersson L; Kjellstrand CM; Saldeen T; Forkman A
    Acta Chir Scand; 1966 Oct; 132(4):466-75. PubMed ID: 5298247
    [No Abstract]   [Full Text] [Related]  

  • 9. [Diagnostic and therapeutic problems problems concerning the simultaneous occurrence of so-called prostatic hypertrophy and cancer].
    Szendröi Z; Csontai A; Korányi E
    Acta Chir Acad Sci Hung; 1972; 13(2):211-20. PubMed ID: 4120167
    [No Abstract]   [Full Text] [Related]  

  • 10. Fine-needle aspiration diagnosis of plasmacytoma presenting as breast masses in a patient on estrogen therapy for prostate cancer.
    Vetto JT; Beer TM; Fidda N; Ham B; Jimenez-Lee R; Schmidt W
    Diagn Cytopathol; 2004 Dec; 31(6):417-9. PubMed ID: 15540181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cancer in the prostate bed after prostatectomy for adenoma].
    Jedlicka D
    Sb Lek; 1982 Dec; 84(11-12):358-60. PubMed ID: 6187059
    [No Abstract]   [Full Text] [Related]  

  • 12. [Endocrinologic aspects of benign prostatic hyperplasia (prostatic adenoma). (Can hormone therapy of the disease be justified in 1984?)].
    Holló I; Horváth C
    Orv Hetil; 1984 Oct; 125(44):2675-8. PubMed ID: 6208526
    [No Abstract]   [Full Text] [Related]  

  • 13. Lactic dehydrogenase isozymes in benign and malignant prostatic tissues.
    Srinivasan V; Keil E; Villalba R; Baron T; Clark SS
    Invest Urol; 1973 Nov; 11(3):244-7. PubMed ID: 4127178
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of cancer of the prostate].
    Vernet SG
    Ann Urol (Paris); 1970 Feb; 4(1):9-16. PubMed ID: 4194186
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunohistochemical analysis of Omi/HtrA2 expression in prostate cancer and benign prostatic hyperplasia.
    Hu XY; Xu YM; Chen XC; Ping H; Chen ZH; Zeng FQ
    APMIS; 2006 Dec; 114(12):893-8. PubMed ID: 17207090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Metabolism of circulating lipids in patients taking oral contraceptives].
    Turpin G; Menage JJ
    Sem Hop; 1973 Oct; 49(43):2833-8. PubMed ID: 4362577
    [No Abstract]   [Full Text] [Related]  

  • 17. Arginase activity in prostatic tissue of patients with benign prostatic hyperplasia and prostatic carcinoma.
    Harris BE; Pretlow TP; Bradley EL; Whitehurst GB; Pretlow TG
    Cancer Res; 1983 Jun; 43(6):3008-12. PubMed ID: 6189588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Editorial comment on: Is there evidence of a relationship between benign prostatic hyperplasia and prostate cancer? Findings of a literature review.
    Novara G
    Eur Urol; 2009 Apr; 55(4):873-4. PubMed ID: 19027221
    [No Abstract]   [Full Text] [Related]  

  • 19. Editorial comment on: Is there evidence of a relationship between benign prostatic hyperplasia and prostate cancer? Findings of a literature review.
    Ahyai SA; Schlomm T
    Eur Urol; 2009 Apr; 55(4):874-5. PubMed ID: 19027220
    [No Abstract]   [Full Text] [Related]  

  • 20. Coagulopathy in prostate cancer.
    de la Fouchardière C; Flechon A; Droz JP
    Neth J Med; 2003 Nov; 61(11):347-54. PubMed ID: 14768717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.